The development of hirudin as an antithrombotic drug.
Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Germany.
F
F
Markwardt
D000595:Amino Acid Sequence; D000818:Animals; D002986:Clinical Trials as Topic; D005818:Genetic Engineering; D014644:Genetic Variation; D006629:Hirudins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D008969:Molecular Sequence Data; D051381:Rats; D011994:Recombinant Proteins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology
D006629:Hirudins; D011994:Recombinant Proteins